Travere Therapeutics Inc (NASDAQ:TVTX)
| 20.96 Delayed Data As of Mar 20 |  -0.22 / -1.04%Today’s Change | 17.82 Today|||52-Week Range 30.35 | -0.33% Year-to-Date |
Latest TVTX News | Press Releases
| 3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing Mar 19 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 21.20 |
| Today’s open | 21.08 |
| Day’s range | 20.68 - 21.23 |
| Volume | 969,447 |
| Average volume (3 months) | 1,198,631 |
| Market cap | $1.6B |
Data as of 3:59pm ET, 03/20/2023
Growth & Valuation
| Earnings growth (last year) | -45.11% |
| Earnings growth (this year) | -2.56% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -6.80% |
| P/E ratio | NM |
| Price/Sales | 6.32 |
| Price/Book | 32.09 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARVNArvinas Inc | +0.53 | +1.77% |
| BCRXBioCryst Pharmaceuti... | -0.09 | -1.11% |
| TLRYTilray Brands Inc | -0.13 | -4.98% |
| MORFMorphic Holding Inc | +0.13 | +0.31% |
Data as of 4:00pm ET, 03/20/2023
Financials
| Next reporting date | May 4, 2023 |
| EPS forecast (this quarter) | -$1.30 |
| Annual revenue (last year) | $212.0M |
| Annual profit (last year) | -$278.5M |
| Net profit margin | -131.35% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
